# Safety and Pharmacokinetic Comparison of Sildenafil ODF and FCT Formulations in Healthy Korean Volunteers

> **NCT01769638** · PHASE1 · COMPLETED · sponsor: **Seoul Pharma Co., Ltd.** · enrollment: 115 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SPO1101
- **DRUG:** SPO1101D

## Key facts

- **NCT ID:** NCT01769638
- **Lead sponsor:** Seoul Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2013-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01769638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01769638, "Safety and Pharmacokinetic Comparison of Sildenafil ODF and FCT Formulations in Healthy Korean Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01769638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*